Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J J Grès"'
Autor:
P Soler-Michel, P Viens, C Fuhrmann, C Rollin, J J Grès, M Viot, A Thyss, H. Curé, D Lefebvre, P Biron
Publikováno v:
Journal of Antimicrobial Chemotherapy. 42:511-518
This open, comparative, randomized, multicentre equivalence study compared cefepime 2 g bd and imipenem-cilastatin 1 g tds (50 mg/kg/day) as empirical monotherapy for febrile episodes in a homogeneous cohort of cancer patients with short duration neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336b700d24d1eec830562e06ed909db0
https://doi.org/10.1093/jac/42.4.511
https://doi.org/10.1093/jac/42.4.511
Autor:
V De Pril, Ashkenazi S, D Kafetzis, J J Grès, C Rollin, Fishbach M, Urs B. Schaad, Eskola J, V Syriopoulou, Boulesteix J
Publikováno v:
The Pediatric Infectious Disease Journal. 17:639-644
Background Cefepime has been used in clinical therapeutic trials for meningitis, serious infection and febrile neutropenia, comprising more than 800 pediatric patients. This agent has also been used in patients 12 years of age and older with uncompli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d148f5e73f07e7c0b2889b66b76eb6ab
https://doi.org/10.1097/00006454-199807000-00012
https://doi.org/10.1097/00006454-199807000-00012
Autor:
E. Bergogne-Berezin, J. J. Grès, R. Cluzel, C. Rollin, A. Thabaut, Patrice Courvalin, Jean Duval, Acar Jf, Claude-James Soussy
Publikováno v:
Journal of Antimicrobial Chemotherapy. 32:55-61
The antimicrobial activity of cefepime, a new broad-spectrum parenteral cephalosporin, was evaluated in vitro against 1757 recent clinical Gram-positive and Gram-negative isolates. Cefepime was active at low concentrations (MIC50 valuesor = 0.06 mg/L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79215480a3d1a8dc82659489cba386be
https://doi.org/10.1093/jac/32.suppl_b.55
https://doi.org/10.1093/jac/32.suppl_b.55
Autor:
J. Leroy, Yves Mouton, Jean-Paul Stahl, J. J. Grès, C. Chidiac, André Bertrand, Modai J, J. Jourdan, Guy Humbert, M. Micoud, C. Rollin, P. Veyssier, Pierre Dellamonica
Publikováno v:
Journal of Antimicrobial Chemotherapy. 32:133-140
Multi-resistant strains of Gram-negative bacteria are rapidly emerging as a frequent cause of serious bacterial infection in the hospital environment. Effective treatment must include an antibiotic with activity against these organisms. In an open mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edde93e63177a797740ad6b090e27660
https://doi.org/10.1093/jac/32.suppl_b.133
https://doi.org/10.1093/jac/32.suppl_b.133
Autor:
U B, Schaad, J, Eskola, D, Kafetzis, M, Fishbach, S, Ashkenazi, V, Syriopoulou, J, Boulesteix, V, De Pril, J J, Grès, C, Rollin
Publikováno v:
The Pediatric infectious disease journal. 17(7)
Cefepime has been used in clinical therapeutic trials for meningitis, serious infection and febrile neutropenia, comprising more than 800 pediatric patients. This agent has also been used in patients 12 years of age and older with uncomplicated and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba214251a3629972218fe9fbd630a4df
https://pubmed.ncbi.nlm.nih.gov/9686732
https://pubmed.ncbi.nlm.nih.gov/9686732
Autor:
N. Lambert-Zechovsky, I. Boucot, Edouard Bingen, Patrick Berche, J. J. Grès, C. Rollin, P. Gehanno
Publikováno v:
The Journal of antimicrobial chemotherapy. 33(6)
Cefprozil is a new oral cephalosporin with activity against the most common pathogens isolated in acute otitis media. This randomized study enrolled 361 patients (mean age 29 months). Physical examination and culture via tympanocentesis were required
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78797660439791a18a1593faaf979b0
https://pubmed.ncbi.nlm.nih.gov/7928814
https://pubmed.ncbi.nlm.nih.gov/7928814
Autor:
J. J. Grès, O. Durbec, Claude Martin, François Gouin, Jacques Albanèse, Y. Domart, C. Rollin, P. Veyssier, J. Leroy, Laurent Papazian
Publikováno v:
The Journal of antimicrobial chemotherapy. 32
Patients in intensive care units (ICUs) are at increased risk of developing nosocomial infections. This is of special concern in the immunocompromised patient, particularly with regard to multiresistant pathogens. We evaluated the effectiveness of ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7103e882987cef32f4851b6090dd243a
https://pubmed.ncbi.nlm.nih.gov/8150764
https://pubmed.ncbi.nlm.nih.gov/8150764
Autor:
F. Lucht, A. Depierre, G. Nouvet, M. Ulmer, C. Rollin, F. Hughes, André Bertrand, P. Delaval, J. F. Muir, J. J. Grès, P. Léophonte
Publikováno v:
The Journal of antimicrobial chemotherapy. 32
Antibiotic treatment for community-acquired pneumonia must target Gram-positive pathogens, especially frequently isolated organisms such as Streptococcus pneumoniae. The severity of community-acquired pneumonia is often related to underlying factors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e685db304b444a3f74c8a283a597f89c
https://pubmed.ncbi.nlm.nih.gov/8150760
https://pubmed.ncbi.nlm.nih.gov/8150760
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Therapie. 41(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f3d5857870b1c111eb862560c9435d0
https://pubmed.ncbi.nlm.nih.gov/2437666
https://pubmed.ncbi.nlm.nih.gov/2437666